Cantaloupe, Inc. - Preferred Stock
Introduktion
Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Douglas L Braunstein. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.
Gennemsnitlig handelsrentabilitet
Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.
Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.
Opdateringsfrekvens: Dagligt
Virksomheder med rapporterede insider-stillinger
SEC-registreringen viser, at Douglas L Braunstein har rapporteret besiddelser eller handler i følgende virksomheder:
| Sikkerhed | Titel | Senest indberettede beholdninger |
|---|---|---|
| US:TALK / Talkspace, Inc. | Director, 10% Owner | 2.026.197 |
| US:CTLP / Cantaloupe, Inc. | 10% Owner | 9.270.694 |
| US:HIII / Hudson Executive Investment Corp III - Class A | President, Chairman, Director | 14.925.000 |
| US:HCII / Hudson Executive Investment Corp II - Class A | President, Chairman, Director | 6.190.000 |
| 10% Owner | 3.491 | |
| US:TVTY / Tivity Health Inc | 10% Owner | 0 |
| US:CVRS / Corindus Vascular Robotics, Inc. | Director | 0 |
| US:EGRX / Eagle Pharmaceuticals, Inc. | Director | 732.777 |
| US:JPM / JPMorgan Chase & Co. | Chief Financial Officer | 109.000 |
Sådan fortolkes diagrammerne
Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Douglas L Braunstein. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.
I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.
Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.
Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.
Insiderkøb CTLPP / Cantaloupe, Inc. - Preferred Stock – kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i CTLPP / Cantaloupe, Inc. - Preferred Stock. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insidersalg CTLPP / Cantaloupe, Inc. - Preferred Stock – kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i CTLPP / Cantaloupe, Inc. - Preferred Stock. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
| Handelsdato | Ticker | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Min |
Pris kl Min |
Max tab Undgået ($) |
Max tab Undgået (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02-21 | CTLP | Hudson Executive Capital LP | 90.582 | 6,3000 | 90.582 | 6,3000 | 570.667 | 31 | 5.2200 | -97.828 | -17,14 |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insiderkøb EGRX / Eagle Pharmaceuticals, Inc. – kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i CTLPP / Cantaloupe, Inc. - Preferred Stock. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insidersalg EGRX / Eagle Pharmaceuticals, Inc. – kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i CTLPP / Cantaloupe, Inc. - Preferred Stock. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insiderkøb HWAY / Themes ETF Trust - Themes US Infrastructure ETF – kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i CTLPP / Cantaloupe, Inc. - Preferred Stock. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
| Handelsdato | Ticker | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Maks |
Pris kl Maks |
Maks Fortjeneste ($) |
Maks. afkast (%) |
|---|---|---|---|---|---|---|---|
| Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insidersalg HWAY / Themes ETF Trust - Themes US Infrastructure ETF – kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i CTLPP / Cantaloupe, Inc. - Preferred Stock. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
| Handelsdato | Ticker | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Min |
Pris kl Min |
Max tab Undgået ($) |
Max tab Undgået (%) |
|---|---|---|---|---|---|---|---|
| Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insiderhandelshistorie
Denne tabel viser den komplette liste over insiderhandler foretaget af Douglas L Braunstein som oplyst til Securities Exchange Commission (SEC).
| Fil dato | Transdato | Form | Ticker | Sikkerhed | Kode | Aktier | Resterende aktier | Procent Lave om |
Del Pris |
Tran Værdi |
Tilbage Værdi |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-03 |
|
4 | TALK |
Talkspace, Inc.
Common Stock |
A - Award | 6.552 | 2.026.197 | 0,32 | ||||
| 2025-06-03 |
|
4 | TALK |
Talkspace, Inc.
Common Stock |
A - Award | 5.757 | 2.019.645 | 0,29 | ||||
| 2025-03-04 |
|
4 | TALK |
Talkspace, Inc.
Common Stock |
A - Award | 6.277 | 2.013.888 | 0,31 | ||||
| 2024-12-12 |
|
4 | TALK |
Talkspace, Inc.
Common Stock |
A - Award | 46.839 | 2.007.611 | 2,39 | ||||
| 2024-12-12 |
|
4 | TALK |
Talkspace, Inc.
Common Stock |
A - Award | 5.123 | 1.960.772 | 0,26 | ||||
| 2024-09-04 |
|
4 | TALK |
Talkspace, Inc.
Common Stock |
A - Award | 9.440 | 1.955.649 | 0,49 | ||||
| 2024-06-26 |
|
4 | TALK |
Talkspace, Inc.
Common Stock |
A - Award | 6.406 | 1.946.209 | 0,33 | 2,91 | 18.641 | 5.663.468 | |
| 2024-03-05 |
|
4 | TALK |
Talkspace, Inc.
Common Stock |
A - Award | 6.014 | 1.939.803 | 0,31 | ||||
| 2024-02-21 |
|
4 | CTLP |
CANTALOUPE, INC.
Common Stock |
S - Sale | -90.582 | 9.270.694 | -0,97 | 6,30 | -570.667 | 58.405.372 | |
| 2024-02-21 |
|
4 | CTLP |
CANTALOUPE, INC.
Common Stock |
J - Other | -2.884.584 | 9.361.276 | -23,56 | ||||
| 2023-12-07 |
|
4 | TALK |
Talkspace, Inc.
Common Stock |
A - Award | 22.038 | 1.933.789 | 1,15 | 2,04 | 44.958 | 3.944.930 | |
| 2023-12-07 |
|
4 | TALK |
Talkspace, Inc.
Common Stock |
A - Award | 78.335 | 1.911.751 | 4,27 | 2,04 | 159.803 | 3.899.972 | |
| 2022-09-28 |
|
4 | TALK |
Talkspace, Inc.
Common Stock |
A - Award | 168.032 | 1.833.416 | 10,09 | 0,95 | 159.630 | 1.741.745 | |
| 2022-05-25 |
|
4 | CTLP |
CANTALOUPE, INC.
Common Stock |
P - Purchase | 17.940 | 12.245.860 | 0,15 | 4,83 | 86.650 | 59.147.504 | |
| 2022-05-25 |
|
4 | CTLP |
CANTALOUPE, INC.
Common Stock |
P - Purchase | 59.305 | 12.227.920 | 0,49 | 4,47 | 265.093 | 54.658.802 | |
| 2022-05-25 |
|
4 | CTLP |
CANTALOUPE, INC.
Common Stock |
P - Purchase | 66.215 | 12.168.615 | 0,55 | 4,50 | 297.968 | 54.758.768 | |
| 2022-05-11 |
|
4 | TALK |
Talkspace, Inc.
Employee Stock Option |
A - Award | 640.000 | 640.000 | |||||
| 2022-05-11 |
|
4 | TALK |
Talkspace, Inc.
Common Stock |
A - Award | 1.650.000 | 1.665.384 | 10.725,43 | ||||
| 2022-03-04 |
|
4 | HIII |
Hudson Executive Investment Corp. III
Class B Common Stock |
P - Purchase | 25.000 | 14.925.000 | 0,17 | ||||
| 2022-02-09 |
|
4 | HCII |
Hudson Executive Investment Corp. II
Class B Common Stock |
S - Sale | -20.000 | 6.190.000 | -0,32 | 0,00 | -58 | 17.951 | |
| 2021-12-29 |
|
4 | CTLP |
CANTALOUPE, INC.
Common Stock |
P - Purchase | 20.000 | 12.102.400 | 0,17 | 7,99 | 159.800 | 96.698.176 | |
| 2021-12-29 |
|
4 | CTLP |
CANTALOUPE, INC.
Common Stock |
P - Purchase | 55.281 | 12.082.400 | 0,46 | 8,07 | 446.118 | 97.504.968 | |
| 2021-12-29 |
|
4 | CTLP |
CANTALOUPE, INC.
Common Stock |
P - Purchase | 31.354 | 12.027.119 | 0,26 | 8,11 | 254.281 | 97.539.935 | |
| 2021-11-24 |
|
4 | TALK |
Talkspace, Inc.
Common Stock |
P - Purchase | 1.000.000 | 11.340.600 | 9,67 | 2,08 | 2.080.000 | 23.588.448 | |
| 2021-10-26 |
|
4 | TALK |
Talkspace, Inc.
Common Stock |
A - Award | 15.384 | 15.384 | |||||
| 2021-08-16 |
|
4 | TALK |
Talkspace, Inc.
Common Stock |
P - Purchase | 142.500 | 17.980.600 | 0,80 | 5,30 | 755.250 | 95.297.180 | |
| 2021-08-16 |
|
4 | TALK |
Talkspace, Inc.
Common Stock |
P - Purchase | 46.000 | 17.838.100 | 0,26 | 5,23 | 240.580 | 93.293.263 | |
| 2021-08-16 |
|
4 | TALK |
Talkspace, Inc.
Common Stock |
P - Purchase | 2.100 | 17.792.100 | 0,01 | 5,17 | 10.857 | 91.985.157 | |
| 2021-07-02 | 3 | TALK |
Talkspace, Inc.
Common Stock |
5.150.000 | ||||||||
| 2021-07-02 | 3 | TALK |
Talkspace, Inc.
Common Stock |
5.000.000 | ||||||||
| 2021-06-24 |
|
4 | TALK |
Talkspace, Inc.
Warrants |
P - Purchase | 2.500.000 | 7.640.000 | 48,64 | 10,00 | 25.000.000 | 76.400.000 | |
| 2021-06-24 |
|
4 | TALK |
Talkspace, Inc.
Stock Options |
A - Award | 63.402 | 63.402 | |||||
| 2021-06-24 |
|
4 | TALK |
Talkspace, Inc.
Warrants |
J - Other | -10.280.000 | 0 | -100,00 | ||||
| 2021-06-24 |
|
4 | TALK |
Talkspace, Inc.
Common Stock |
P - Purchase | 5.000.000 | 10.150.000 | 97,09 | 10,00 | 50.000.000 | 101.500.000 | |
| 2021-06-24 |
|
4 | TALK |
Talkspace, Inc.
Common Stock |
J - Other | -10.300.000 | 0 | -100,00 | ||||
| 2021-05-14 |
|
4 | CTLP |
CANTALOUPE, INC.
Common Stock |
A - Award | 9.606 | 25.015 | 62,34 | ||||
| 2021-04-14 |
|
4 | HIII |
Hudson Executive Investment Corp. III
Class B Common Stock |
J - Other | -93.750 | 14.900.000 | -0,63 | ||||
| 2021-04-14 |
|
4 | HCII |
Hudson Executive Investment Corp. II
Class B Common Stock |
S - Sale | -40.000 | 6.210.000 | -0,64 | 0,00 | -116 | 18.009 | |
| 2021-04-14 |
|
4 | HCII |
Hudson Executive Investment Corp. II
Class B Common Stock |
J - Other | -218.750 | 6.250.000 | -3,38 | ||||
| 2021-03-11 |
|
4 | CATM |
Cardtronics plc
Restricted Stock Units |
A - Award | 3.491 | 3.491 | |||||
| 2021-03-11 |
|
4 | CATM |
Cardtronics plc
Restricted Stock Units |
M - Exercise | -5.952 | 0 | -100,00 | ||||
| 2021-03-11 |
|
4 | CATM |
Cardtronics plc
Ordinary Shares |
M - Exercise | 5.952 | 14.040 | 73,59 | ||||
| 2021-02-26 |
|
4 | USAT |
USA TECHNOLOGIES INC
Common Stock |
A - Award | 975.000 | 11.995.765 | 8,85 | 9,60 | 9.360.000 | 115.159.344 | |
| 2020-07-02 |
|
4 | USAT |
USA TECHNOLOGIES INC
Common Stock |
A - Award | 635.593 | 11.020.765 | 6,12 | ||||
| 2020-06-29 |
|
4 | CATM |
Cardtronics plc
Ordinary Shares |
P - Purchase | 24.200 | 8.652.968 | 0,28 | 23,30 | 563.860 | 201.614.154 | |
| 2020-06-29 |
|
4 | CATM |
Cardtronics plc
Ordinary Shares |
P - Purchase | 145.800 | 8.628.768 | 1,72 | 22,45 | 3.273.210 | 193.715.842 | |
| 2020-06-29 |
|
4 | CATM |
Cardtronics plc
Ordinary Shares |
P - Purchase | 1.520 | 8.482.968 | 0,02 | 24,75 | 37.620 | 209.953.458 | |
| 2020-06-29 |
|
4 | CATM |
Cardtronics plc
Ordinary Shares |
P - Purchase | 98.480 | 8.481.448 | 1,17 | 24,09 | 2.372.383 | 204.318.082 | |
| 2020-06-23 |
|
4 | CATM |
Cardtronics plc
Ordinary Shares |
P - Purchase | 75.350 | 8.374.880 | 0,91 | 24,34 | 1.834.019 | 203.844.579 | |
| 2020-06-23 |
|
4 | CATM |
Cardtronics plc
Ordinary Shares |
P - Purchase | 100 | 8.299.530 | 0,00 | 23,24 | 2.324 | 192.881.077 | |
| 2020-06-23 |
|
4 | CATM |
Cardtronics plc
Ordinary Shares |
P - Purchase | 133.474 | 8.299.430 | 1,63 | 23,74 | 3.168.673 | 197.028.468 | |
| 2020-06-08 |
|
4 | HEC |
Hudson Executive Investment Corp.
Class B Common Stock |
J - Other | 1.725.000 | 10.300.000 | 20,12 | ||||
| 2020-05-22 |
|
4 | USAT |
USA TECHNOLOGIES INC
Non-Qualified Stock Option (Right to Buy) |
A - Award | 120.000 | 120.000 | |||||
| 2020-05-19 |
|
4 | CATM |
Cardtronics plc
Ordinary Shares |
P - Purchase | 39.023 | 8.165.956 | 0,48 | 18,94 | 739.096 | 154.663.207 | |
| 2020-05-11 |
|
4 | TVTY |
TIVITY HEALTH, INC.
Long Put Option (right to sell) |
D - Sale to Issuer | -43.776 | 0 | -100,00 | 0,60 | -26.266 | ||
| 2020-05-11 |
|
4 | TVTY |
TIVITY HEALTH, INC.
Short Call Option (obligation to sell) |
J - Other | 43.776 | 0 | -100,00 | 3,85 | 168.538 | ||
| 2020-05-11 |
|
4 | TVTY |
TIVITY HEALTH, INC.
Common Stock |
D - Sale to Issuer | -3.960.000 | 4.795.310 | -45,23 | 12,20 | -48.312.000 | 58.502.782 | |
| 2020-05-08 |
|
4 | USAT |
USA TECHNOLOGIES INC
Common Stock |
A - Award | 15.409 | 15.409 | |||||
| 2020-04-02 |
|
4 | CATM |
Cardtronics plc
Restricted Stock Units |
A - Award | 5.952 | 5.952 | |||||
| 2020-03-13 | 3 | TVTY |
TIVITY HEALTH, INC.
Common Stock |
17.510.620 | ||||||||
| 2020-03-13 | 3 | TVTY |
TIVITY HEALTH, INC.
Common Stock |
17.510.620 | ||||||||
| 2020-03-13 | 3 | TVTY |
TIVITY HEALTH, INC.
Common Stock |
17.510.620 | ||||||||
| 2020-03-13 | 3 | TVTY |
TIVITY HEALTH, INC.
Common Stock |
17.510.620 | ||||||||
| 2020-03-13 | 3 | TVTY |
TIVITY HEALTH, INC.
Common Stock |
17.510.620 | ||||||||
| 2020-03-11 |
|
4 | CATM |
Cardtronics plc
Restricted Stock Units |
M - Exercise | -4.278 | 0 | -100,00 | ||||
| 2020-03-11 |
|
4 | CATM |
Cardtronics plc
Ordinary Shares |
M - Exercise | 4.278 | 8.135.021 | 0,05 | ||||
| 2020-03-06 |
|
4 | USAT |
USA TECHNOLOGIES INC
Long Put Option (right to sell) |
J - Other | 5.300 | 0 | -100,00 | 0,70 | 3.710 | ||
| 2020-03-06 |
|
4/A | USAT |
USA TECHNOLOGIES INC
Short Put Option (obligation to buy) |
S - Sale | -5.300 | 5.300 | -50,00 | 1,40 | -7.420 | 7.420 | |
| 2019-10-31 |
|
4 | CVRS |
Corindus Vascular Robotics, Inc.
Common Stock Purchase Warrant |
D - Sale to Issuer | -4.725.000 | 0 | -100,00 | 4,28 | -20.223.000 | ||
| 2019-10-31 |
|
4 | CVRS |
Corindus Vascular Robotics, Inc.
Series A-1 Preferred Stock |
D - Sale to Issuer | -105.281 | 0 | -100,00 | 85,60 | -9.012.072 | ||
| 2019-10-31 |
|
4 | CVRS |
Corindus Vascular Robotics, Inc.
Series A Preferred Stock |
D - Sale to Issuer | -540.000 | 0 | -100,00 | 85,60 | -46.224.000 | ||
| 2019-10-31 |
|
4 | CVRS |
Corindus Vascular Robotics, Inc.
Common Stock |
D - Sale to Issuer | -14.235.545 | 0 | -100,00 | 4,28 | -60.928.133 | ||
| 2019-10-31 |
|
4 | CVRS |
Corindus Vascular Robotics, Inc.
Common Stock |
D - Sale to Issuer | -106.219 | 0 | -100,00 | 4,28 | -454.617 | ||
| 2019-10-28 |
|
4 | EGRX |
EAGLE PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -15.437 | 732.777 | -2,06 | 63,57 | -981.302 | 46.581.315 |
| 2019-10-28 |
|
4 | EGRX |
EAGLE PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -1.494 | 748.214 | -0,20 | 62,53 | -93.412 | 46.782.155 |
| 2019-10-23 |
|
4 | EGRX |
EAGLE PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -200 | 749.708 | -0,03 | 62,58 | -12.516 | 46.916.727 |
| 2019-10-23 |
|
4 | EGRX |
EAGLE PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -6.567 | 749.908 | -0,87 | 62,68 | -411.618 | 47.004.008 |
| 2019-10-23 |
|
4 | EGRX |
EAGLE PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -3.849 | 756.475 | -0,51 | 62,56 | -240.791 | 47.324.546 |
| 2019-10-18 |
|
4 | EGRX |
EAGLE PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -1.600 | 760.324 | -0,21 | 62,61 | -100.174 | 47.602.973 |
| 2019-10-18 |
|
4 | EGRX |
EAGLE PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -13.842 | 761.924 | -1,78 | 62,58 | -866.196 | 47.679.223 |
| 2019-10-18 |
|
4 | EGRX |
EAGLE PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -102 | 775.766 | -0,01 | 62,50 | -6.375 | 48.485.375 |
| 2019-10-16 |
|
4 | USAT |
USA TECHNOLOGIES INC
Common Stock |
P - Purchase | 165.000 | 10.385.172 | 1,61 | 7,26 | 1.198.494 | 75.433.735 | |
| 2019-10-16 |
|
4 | USAT |
USA TECHNOLOGIES INC
Common Stock |
P - Purchase | 80.000 | 10.220.172 | 0,79 | 6,70 | 536.024 | 68.478.218 | |
| 2019-10-15 |
|
4 | EGRX |
EAGLE PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -3.909 | 775.868 | -0,50 | 62,63 | -244.836 | 48.595.639 |
| 2019-10-15 |
|
4 | EGRX |
EAGLE PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -16.300 | 779.777 | -2,05 | 60,39 | -984.419 | 47.093.696 |
| 2019-10-15 |
|
4 | EGRX |
EAGLE PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -7.829 | 796.077 | -0,97 | 60,16 | -471.002 | 47.892.948 |
| 2019-10-09 |
|
4 | EGRX |
EAGLE PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -1.558 | 803.906 | -0,19 | 60,03 | -93.520 | 48.254.860 |
| 2019-10-09 |
|
4 | EGRX |
EAGLE PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -4.901 | 805.464 | -0,60 | 60,11 | -294.600 | 48.416.522 |
| 2019-10-09 |
|
4 | CVRS |
Corindus Vascular Robotics, Inc.
Common Stock |
A - Award | 1.170 | 106.219 | 1,11 | 4,27 | 4.996 | 453.555 | |
| 2019-09-26 |
|
4 | USAT |
USA TECHNOLOGIES INC
Common Stock |
P - Purchase | 605.000 | 10.140.172 | 6,34 | 4,86 | 2.943.325 | 49.331.937 | |
| 2019-09-26 |
|
4 | USAT |
USA TECHNOLOGIES INC
Common Stock |
P - Purchase | 1.176.000 | 9.535.172 | 14,07 | 4,43 | 5.213.914 | 42.275.139 | |
| 2019-09-26 |
|
4 | USAT |
USA TECHNOLOGIES INC
Common Stock |
P - Purchase | 20.000 | 8.359.172 | 0,24 | 4,40 | 88.000 | 36.780.357 | |
| 2019-09-23 |
|
4 | USAT |
USA TECHNOLOGIES INC
Common Stock |
P - Purchase | 143.200 | 8.339.172 | 1,75 | 4,46 | 638.672 | 37.192.707 | |
| 2019-09-23 |
|
4 | USAT |
USA TECHNOLOGIES INC
Call Option (right to buy) |
P - Purchase | 12.500 | 12.500 | 0,50 | 6.250 | 6.250 | ||
| 2019-09-19 |
|
4 | EGRX |
EAGLE PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -100 | 810.365 | -0,01 | 60,00 | -6.000 | 48.621.900 |
| 2019-09-13 |
|
4 | EGRX |
EAGLE PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -200 | 810.465 | -0,02 | 60,07 | -12.014 | 48.684.633 |
| 2019-09-13 |
|
4 | EGRX |
EAGLE PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -1.112 | 810.665 | -0,14 | 60,06 | -66.785 | 48.687.243 |
| 2019-08-05 |
|
4 | USAT |
USA TECHNOLOGIES INC
Short Put Option (obligation to buy) |
S - Sale | -5.300 | 5.300 | -50,00 | 1,40 | -7.420 | 7.420 | |
| 2019-08-05 |
|
4 | USAT |
USA TECHNOLOGIES INC
Common Stock |
P - Purchase | 1.000.252 | 8.195.972 | 13,90 | 6,93 | 6.931.746 | 56.798.086 | |
| 2019-07-10 |
|
4 | CVRS |
Corindus Vascular Robotics, Inc.
Common Stock |
A - Award | 1.453 | 105.049 | 1,40 | 3,44 | 4.998 | 361.369 | |
| 2019-05-20 | 3 | USAT |
USA TECHNOLOGIES INC
Common Stock |
14.391.440 | ||||||||
| 2019-05-20 | 3 | USAT |
USA TECHNOLOGIES INC
Common Stock |
14.391.440 | ||||||||
| 2019-05-20 | 3 | USAT |
USA TECHNOLOGIES INC
Common Stock |
14.391.440 | ||||||||
| 2019-05-20 | 3 | USAT |
USA TECHNOLOGIES INC
Common Stock |
14.391.440 | ||||||||
| 2019-05-20 | 3 | USAT |
USA TECHNOLOGIES INC
Common Stock |
14.391.440 | ||||||||
| 2019-05-13 |
|
4 | EGRX |
EAGLE PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -100.000 | 811.777 | -10,97 | 56,14 | -5.614.000 | 45.573.161 | |
| 2019-05-13 |
|
4 | EGRX |
EAGLE PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -59.223 | 911.777 | -6,10 | 57,95 | -3.431.973 | 52.837.477 | |
| 2019-05-07 |
|
4 | CVRS |
Corindus Vascular Robotics, Inc.
Common Stock |
A - Award | 27.649 | 103.596 | 36,41 | 2,17 | 59.998 | 224.803 | |
| 2019-04-09 |
|
4 | CVRS |
Corindus Vascular Robotics, Inc.
Common Stock |
A - Award | 2.358 | 75.947 | 3,20 | 2,12 | 4.999 | 161.008 | |
| 2019-03-15 |
|
4 | CATM |
Cardtronics plc
Restricted Stock Units |
A - Award | 4.278 | 4.278 | |||||
| 2019-03-14 |
|
4 | CVRS |
Corindus Vascular Robotics, Inc.
Common Stock |
P - Purchase | 2.899.391 | 14.235.545 | 25,58 | 1,38 | 4.000.000 | 19.639.358 | |
| 2019-03-12 |
|
4 | CATM |
Cardtronics plc
Restricted Stock Units |
M - Exercise | -3.810 | 0 | -100,00 | ||||
| 2019-03-12 |
|
4 | CATM |
Cardtronics plc
Ordinary Shares |
M - Exercise | 3.810 | 8.130.743 | 0,05 | ||||
| 2019-01-25 |
|
4 | EGRX |
EAGLE PHARMACEUTICALS, INC.
Stock Option (right to buy) |
A - Award | 10.000 | 10.000 | |||||
| 2019-01-10 |
|
4 | CVRS |
Corindus Vascular Robotics, Inc.
Common Stock |
A - Award | 5.357 | 73.589 | 7,85 | 1,12 | 6.000 | 82.420 | |
| 2018-10-09 |
|
4 | CVRS |
Corindus Vascular Robotics, Inc.
Common Stock |
A - Award | 3.200 | 68.232 | 4,92 | 1,25 | 4.000 | 85.290 | |
| 2018-08-15 |
|
4 | CATM |
Cardtronics plc
Ordinary Shares |
P - Purchase | 54.898 | 8.126.933 | 0,68 | 29,89 | 1.640.901 | 242.914.027 | |
| 2018-08-10 |
|
4 | CATM |
Cardtronics plc
Ordinary Shares |
P - Purchase | 12.350 | 8.072.035 | 0,15 | 30,22 | 373.217 | 243.936.898 | |
| 2018-08-10 |
|
4 | CATM |
Cardtronics plc
Ordinary Shares |
P - Purchase | 12.850 | 8.059.685 | 0,16 | 29,73 | 382.030 | 239.614.435 | |
| 2018-07-11 |
|
4 | CVRS |
Corindus Vascular Robotics, Inc.
Common Stock |
A - Award | 4.273 | 65.032 | 7,03 | 1,17 | 4.999 | 76.087 | |
| 2018-06-22 |
|
4 | CATM |
Cardtronics plc
Restricted Stock Units |
A - Award | 3.810 | 3.810 | |||||
| 2018-06-04 |
|
4 | CVRS |
Corindus Vascular Robotics, Inc.
Common Stock |
A - Award | 53.326 | 60.759 | 717,42 | 0,75 | 40.000 | 45.575 | |
| 2018-05-04 |
|
4 | CATM |
Cardtronics plc
Ordinary Shares |
P - Purchase | 24.000 | 8.046.835 | 0,30 | 25,34 | 608.160 | 203.906.799 | |
| 2018-05-04 |
|
4 | CATM |
Cardtronics plc
Ordinary Shares |
P - Purchase | 119.000 | 8.022.835 | 1,51 | 25,32 | 3.013.080 | 203.138.182 | |
| 2018-04-30 |
|
4 | CATM |
Cardtronics plc
Ordinary Shares |
P - Purchase | 122.150 | 7.903.835 | 1,57 | 25,92 | 3.166.128 | 204.867.403 | |
| 2018-04-30 |
|
4 | CATM |
Cardtronics plc
Ordinary Shares |
P - Purchase | 85.000 | 7.781.685 | 1,10 | 25,87 | 2.198.950 | 201.312.191 | |
| 2018-04-24 |
|
4 | CATM |
Cardtronics plc
Ordinary Shares |
P - Purchase | 350.500 | 7.696.685 | 4,77 | 25,39 | 8.899.195 | 195.418.832 | |
| 2018-04-13 |
|
4 | CATM |
Cardtronics plc
Ordinary Shares |
P - Purchase | 958.355 | 7.346.185 | 15,00 | 23,55 | 22.569.260 | 173.002.657 | |
| 2018-04-10 |
|
4 | CVRS |
Corindus Vascular Robotics, Inc.
Common Stock |
A - Award | 653 | 7.433 | 9,63 | 1,36 | 888 | 10.109 | |
| 2018-04-02 |
|
4 | CATM |
Cardtronics plc
Ordinary Shares |
P - Purchase | 63.100 | 6.387.830 | 1,00 | 22,47 | 1.417.857 | 143.534.540 | |
| 2018-03-20 | 3 | CVRS |
Corindus Vascular Robotics, Inc.
Common Stock |
22.672.308 | ||||||||
| 2018-03-20 | 3 | CVRS |
Corindus Vascular Robotics, Inc.
Common Stock |
22.672.308 | ||||||||
| 2018-03-20 | 3 | CVRS |
Corindus Vascular Robotics, Inc.
Common Stock |
22.672.308 | ||||||||
| 2018-03-20 |
|
4 | CVRS |
Corindus Vascular Robotics, Inc.
Common Stock |
A - Award | 6.780 | 6.780 | |||||
| 2018-02-23 |
|
4 | CATM |
Cardtronics plc
Ordinary Shares |
P - Purchase | 5.810 | 6.324.730 | 0,09 | 24,00 | 139.440 | 151.793.520 | |
| 2018-02-23 |
|
4 | CATM |
Cardtronics plc
Ordinary Shares |
P - Purchase | 278.402 | 6.318.920 | 4,61 | 23,39 | 6.511.823 | 147.799.539 | |
| 2018-02-23 |
|
4 | CATM |
Cardtronics plc
Ordinary Shares |
P - Purchase | 37.788 | 6.040.518 | 0,63 | 22,73 | 858.921 | 137.300.974 | |
| 2018-01-31 | 3 | CATM |
Cardtronics plc
Ordinary Shares |
12.005.460 | ||||||||
| 2018-01-31 | 3 | CATM |
Cardtronics plc
Ordinary Shares |
12.005.460 | ||||||||
| 2018-01-31 | 3 | CATM |
Cardtronics plc
Ordinary Shares |
12.005.460 | ||||||||
| 2018-01-31 | 3 | CATM |
Cardtronics plc
Ordinary Shares |
12.005.460 | ||||||||
| 2018-01-09 |
|
4 | EGRX |
EAGLE PHARMACEUTICALS, INC.
Stock Option (Right to Buy) |
A - Award | 10.000 | 10.000 | |||||
| 2017-08-11 |
|
4 | EGRX |
EAGLE PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.584 | 971.000 | 0,16 | 50,09 | 79.338 | 48.634.865 | |
| 2017-08-11 |
|
4 | EGRX |
EAGLE PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 15.206 | 969.416 | 1,59 | 49,21 | 748.258 | 47.703.119 | |
| 2017-08-11 |
|
4 | EGRX |
EAGLE PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 3.610 | 954.210 | 0,38 | 48,06 | 173.490 | 45.857.520 | |
| 2017-01-06 |
|
4 | EGRX |
EAGLE PHARMACEUTICALS, INC.
Stock Option (right to buy) |
A - Award | 10.000 | 10.000 | |||||
| 2016-07-06 |
|
4 | EGRX |
EAGLE PHARMACEUTICALS, INC.
Stock Option (right to buy) |
A - Award | 10.000 | 10.000 | |||||
| 2016-07-06 | 3 | EGRX |
EAGLE PHARMACEUTICALS, INC.
Common Stock |
1.901.200 | ||||||||
| 2016-07-06 | 3 | EGRX |
EAGLE PHARMACEUTICALS, INC.
Common Stock |
1.901.200 | ||||||||
| 2013-01-04 |
|
4 | JPM |
JPMORGAN CHASE & CO
Common Stock |
G - Gift | 109.000 | 109.000 | |||||
| 2013-01-04 |
|
4 | JPM |
JPMORGAN CHASE & CO
Common Stock |
G - Gift | -109.000 | 470.836 | -18,80 | ||||
| 2013-01-04 |
|
4 | JPM |
JPMORGAN CHASE & CO
Common Stock |
G - Gift | 24.000 | 24.000 | |||||
| 2013-01-04 |
|
4 | JPM |
JPMORGAN CHASE & CO
Common Stock |
G - Gift | -24.000 | 0 | -100,00 | ||||
| 2013-01-04 |
|
4 | JPM |
JPMORGAN CHASE & CO
Common Stock |
G - Gift | 24.000 | 24.000 | |||||
| 2013-01-04 |
|
4 | JPM |
JPMORGAN CHASE & CO
Common Stock |
G - Gift | -24.000 | 579.836 | -3,97 | ||||
| 2012-01-20 |
|
4 | JPM |
JPMORGAN CHASE & CO
Stock Appreciation Rights |
A - Award | 168.729 | 168.729 | |||||
| 2012-01-20 |
|
4 | JPM |
JPMORGAN CHASE & CO
Restricted Stock Units |
A - Award | 122.174 | 122.174 | |||||
| 2012-01-18 |
|
4 | JPM |
JPMORGAN CHASE & CO
Common Stock |
F - Taxes | -92.149 | 603.836 | -13,24 | 35,52 | -3.273.593 | 21.451.274 | |
| 2010-07-02 | 3 | JPM |
J P MORGAN CHASE & CO
Common Stock |
847.951 | ||||||||
| 2010-07-02 | 3 | JPM |
J P MORGAN CHASE & CO
Common Stock |
457 |
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
